1.
J Craniofac Surg
; 27(7): 1802-1803, 2016 Oct.
Article
in English
| MEDLINE
| ID: mdl-27513783
ABSTRACT
Though the lymphangioma is a benign neoplasm, it may make an invasion to vital structures by progressively growing. For lymphangioma, which progressed in such a way, surgical treatment has high morbidity and recurrence risk. On these cases, OK-432 is a frequently used sclerotherapy agent. The authors report the result they obtained by the use of single-dose OK-432 on an inoperable pediatric cervical macrocystic lymphangioma case and also their experiences.